Toyonaka, Japan

Nobuto Kanagawa

This inventor holds 3 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Morishita Jintan Co., Ltd.. Active years: 1987-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuto Kanagawa. Retrieved from https://idiyas.com/inventor/nobuto-kanagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 41(Granted Patents)


Location History:

  • Kyogo, JP (1987)
  • Toyonaka, JP (1992)
  • Takaoka, JP (1995)

Company Filing History:


Years Active: 1987-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Nobuto Kanagawa

Introduction

Nobuto Kanagawa is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ointments and cyclic peptides. With a total of 3 patents to his name, Kanagawa's work has had a meaningful impact on the treatment of various skin diseases and allergic conditions.

Latest Patents

One of Kanagawa's latest patents is an ointment containing FK-506 or its derivatives. This ointment comprises a tricyclic compound, specifically FK 506, which is useful for treating various skin diseases. Another significant patent is the preparation of FR115224 substrate for parenteral administration. This cyclic peptide, designated FR115224, is administered parenterally in a cyclodextrin carrier and exhibits antiallergic activity.

Career Highlights

Throughout his career, Nobuto Kanagawa has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Morishita Jintan Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Kanagawa has collaborated with several professionals in his field, including Sotoo Asakura and Takehisa Hata. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Nobuto Kanagawa's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventions. His patents reflect a dedication to addressing significant medical challenges, particularly in dermatology and allergy treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…